Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026)
Glass House Brands' (GLAS) quarterly Net Equity Issued and Repurchased came in at $22.3 million in Q1 2026, up 104.61% on a QoQ basis from $10.9 million in Q3 2023.
Glass House Brands (GLAS) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $22.3 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $22.3 million in Q1 2026; TTM through Mar 2026 was $33.5 million, a N/A change from a year earlier, with the FY2022 full-year figure at $303694.0, down 99.76% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $22.3 million, up from $10.9 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for GLAS reached as high as $22.3 million in Q1 2026 and fell as low as -$19.2 million in Q4 2022.
- Historically, Net Equity Issued and Repurchased has averaged $2.9 million across 3 years, with a median of $300000.0 in 2023.
- Across the five-year window, Net Equity Issued and Repurchased plunged 4318.51% in 2022 and jumped 200.31% in 2023, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at -$19.2 million in 2022, then jumped by 156.78% to $10.9 million in 2023, then jumped by 104.61% to $22.3 million in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $22.3 million in Q1 2026, $10.9 million in Q3 2023, and $300000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.30 Mn |
| Mar 31, 2026 | 22.30 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | -19.20 Mn |
| Dec 31, 2022 | -19.20 Mn |
| Mar 31, 2022 | 99,898.00 |
| Mar 31, 2022 | 99,898.00 |
| Dec 31, 2021 | 455,054.00 |
| Dec 31, 2021 | 455,054.00 |
| Sep 30, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |